| PTX | Paclitaxel |
| NCI | National Cancer Institute |
| T. brevifolia | Taxus brevifolia |
| BMS | Bristol-Myers Squibb |
| FDA | Food and Drug Administration |
| EMA | European Medicines Agency |
| NSCLC | Non-small-cell lung carcinoma |
| PDAC | Pancreatic ductal adenocarcinoma |
| MVA | Mevalonate |
| MEP | methylerythritol phosphate |
| IPP | Isopentenyl pyrophosphate |
| DMAPP | Dimethylalyl pyrophosphate |
| taxadiene | Taxa-4(5),11(12)-diene |
| IDI | Isopentenyldiphosphate isomerase |
| GPPS | Geranylpyrophosphate synthase |
| GGPPS | Geranylgeranylpyrophosphate synthase |
| 10-DAB | 10-deacetyl baccatin III |
| E. coli | Escherichia coli |
| S. cerevisiae | Sacharomyces cerevisiae |
| B. subtillis | Bacillus subtilis |
| CrEL | Cremophor EL |
| MTD | Maximum authorized dose |
| ROS | Reactive-oxygen species |
| GSH | Glutathione |
| PEG | polyethylenglycoly |
| AUC | Area under the concentration–time curve |
| P-gp | P-glycoprotein |
| mPEG-PDLLA | Monomethoxy-poly (ethylene glycol)-block-poly(d,l-lactide) |
| PVP-b-PNIPAAM | poly-(vinylpyrrolidone)-b–poly-(N-isopropyl acryl-amide) |
| WHO | Word Health Organization |
| MTA | Microtubule Targeting Agent |
| ER | Endoplasmic reticulum |
| Bcl-2 | B-cell Leukemia 2 |
| BAX | Bcl-2-associated X protein |
| MMP | Mitochondrial membrane potential |
| ATG5 | Autophagy protein 5 |
| TLR4 | Toll-like receptor 4 |
| PAMPs | Pathogen-associated molecular patterns |
| HIF-1 | Hypoxia-inducible factor 1 |
| KRT17 | keratin 17 |
| FNDC5 | Fibronectin type III domain-containing protein 5 |
| MDR1 | Multidrug resistance-associated protein 1 |
| ABC | ATP-binding cassette |
| RTK | Receptor tyrosine kinase |
| TKIs | Inhibitors of receptor tyrosine kinases |
| MUC-1 | Mucin 1 |
| PFL | Penfluridol |
| FoxM1 | Forkhead protein 1 |
| PHB1 | Prohibitin 1 |
| SSTA | Somatostatin analogue |
| SSTR | Somatostatin receptor |
| MAPK | Mitogen-Activated Protein Kinase |
| LdA | Lactate dehydrogenase |
| Pdk2 | Pyruvate dehydrogenase kinase 2 |
| PN | Peripheral neuropathy (PN) |
| lncRNA | Long noncoding RNA |
| EGOT | Eosinophil granule ontogeny transcript |
| FER1L4 | Fer-1-like family member 4 |
| LINC-PINT | lncRNA intergenic non-protein-coding RNA p53-induced transcript |
| UCA1 | Urothelial Carcinoma-Associated 1 |
| ABCB1 | ATP Binding Cassette Subfamily B Member |
| LINC01118 | Long Intergenic Non-Coding RNA 1118 |
| lncRNA SDHAP1 | LnRNA succinate dehydrogenase complex flavoprotein subunit A pseudogene 1 |
| EIF4G2 | Eukaryotic translation initiation factor 4 gamma 2 |
| CCAT1 | Colon cancer-associated transcript 1 |
| FSCN1 | Fascin1 |
| CAAs | Cancer-associated adipocytes |
| CAFs | Cancer-associated fibroblasts |
| (CTSL | Cathepsin L |
| SIK2 | Salt-inducible kinase 2 |
| IKBKB | IκB kinase β |
| E2F5 | E2F transcription factor 5 |
| MCT1 | Monocarboxylic acid solute transporter 1 |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| ITGB1 | Upregulation of integrin beta-1 |
| ITPR1 | Inositol 1,4,5-Trisphosphate Receptor Type 1 |